UK markets closed
NIKKEI 225
39,103.22 +486.12 (+1.26%) HANG SENG
18,868.71 -326.89 (-1.70%) CRUDE OIL
76.93 +0.06 (+0.08%) GOLD FUTURES
2,331.70 -5.50 (-0.24%) DOW
39,065.26 -605.78 (-1.53%) Bitcoin GBP
53,323.08 -1,275.21 (-2.34%)
AbbVie Inc. (4AB.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:43PM CEST
| Previous close | 146.90 |
| Open | 147.32 |
| Bid | 146.28 x 60000 |
| Ask | 146.74 x 60000 |
| Day's range | 145.64 - 148.74 |
| 52-week range | 119.00 - 168.80 |
| Volume | |
| Avg. volume | 199 |
| Market cap | 260.721B |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | 47.58 |
| EPS (TTM) | 3.10 |
| Earnings date | 25 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | 5.73 (3.90%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | 127.01 |
PR NewswireAbbVie Completes Acquisition of Landos Biopharma
AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP). With the completion of the acquisition, Landos is now part of AbbVie.
ZacksWhy AbbVie (ABBV) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ZacksLilly (LLY) Hits Record High on Crohn's Disease Study Data
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.
© 2024 Yahoo. All rights reserved.